| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Chairman &CEO
1 company
Patel Sanj K is a Chairman &CEO at KNSA. Recent filings cover 0 purchases and 39 sales.
Our model assigns Patel Sanj K a below-average insider score of 38/100, based on 16 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -66.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sell | 65,012 | $21.02 | $1,366,552.24 | -100% | -7.3% | +1.2% | |
| Mar 6, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sell | 18,324 | $21.34 | $391,055.86 | -22.0% | -8.0% | +1.3% | |
| Feb 10, 2021 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 56,159 | $23.05 | $1,294,534.15 | -40.3% | - | - | |
| Oct 12, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 251,572 | $21.02 | $5,288,012.60 | -69.1% | - | - | |
| Mar 6, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sell | 33,115 | $20.00 | $662,300.00 | -13.5% | - | - |